Status of work in October
In October, AOTMiT begins work on orders from the Minister of Health:
- Vyloy (zolbetuximab) for the treatment of patients with esophageal, gastroesophageal junction, and gastric cancer
- Darzalex (daratumumab) for the treatment of patients with multiple myeloma
- Tremfya (guselkumab) for the treatment of patients with ulcerative colitis (UC)
- Tremfya (guselkumab) for treating patients with Crohn’s disease
The listed order is available on the AOTMiT Public Information Bulletin.